- Price is above Fair Value, showing premium demand versus the model.
- Next-week expectancy is positive at 59.21% based on similar historical setup states.
H02
SES
Week ended 07 Aug 2026
Weekly Investor Report
Haw Par Corporation Limited · Healthcare · Drug Manufacturers - General
Latest close
16.03 SGD
-0.4%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -2.0% below the Trend Line and sits at 54.7% of its 52-week range. The latest completed week returned -0.4%, after a -4.0% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
43
out of 100
Latest Close
16.03 SGD
7 Aug 2026
1W Return
-0.4%
latest completed week
4W Return
-4.0%
short-term follow-through
12W Return
-4.6%
quarterly tape
Trend Breadth
80.8%
42 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.4%
Latest completed week; four-week move -4.0%.
Indicator stack
44/33
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 59.21%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
4 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -2.0% below the Trend Line and sits at 54.7% of its 52-week range. The latest completed week returned -0.4%, after a -4.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3112-week average 0.60
12-week confirmation
Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.31Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -4.0% over four weeks, -4.6% over 12 weeks, and 16.9% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year42
Trend breadth80.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.92Latest activity-pressure read.
Pressure change-8.2%Four-week change in activity pressure.
Leadership-14.02Latest relative-leadership reading.
RS change-95.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 4 relevant articles.
0 positive · 4 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-11.2%Distance below the 52-week high.
13-week volatility3.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2615 weeks finished lower.
Best week+7.4%Week of 27 Mar.
Worst week-7.5%Week of 29 May.
Latest week-0.4%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains6
Flat weeks0
Modest losses13
Sharp losses2
Recent vol3.0%13-week weekly-return volatility.
Base vol3.0%52-week weekly-return volatility.
Up/down split28/22Count of positive and negative weeks in the 52-week window.
Average skew2.5% / -2.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSG Healthcare
4-week rank23 / 35
Group average1.0%
Trend breadth28.6%
Trend28.6%active weekly trend signals
MD31.4%positive activity pressure
RS20.0%positive relative leadership
Four-week leaders
IndustrySG Drug Manufacturers - General
4-week rank1 / 1
Group average-4.0%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD0.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape44/100
Trend, activity pressure, participation, and risk combine to a 44/100 tape read.
Indicator analysis20/100Latest 12-week confirmation: trend 2/12, activity pressure 0/12, relative leadership 1/12.
Activity pressure 0.31; No reversal markers Next-Week ExpectancyPositive 59.21%Next-week expectancy is positive with a 59.21% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 4 relevant articles.
Haw Par Corporation Limited's (SGX:H02) top owners are retail investors with 37% stake, while 36% is held by private companies Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 16.03 SGD | -0.4% | 16.36 SGD | 11.57 SGD | -0.92 | -14.02 | 884.1K | Off |
| 31 Jul 2026 | 16.10 SGD | -0.4% | 16.36 SGD | 11.52 SGD | -0.82 | -12.79 | 1.1M | Off |
| 24 Jul 2026 | 16.17 SGD | -1.3% | 16.35 SGD | 11.47 SGD | -0.88 | -11.99 | 666.9K | Off |
| 17 Jul 2026 | 16.39 SGD | -1.9% | 16.33 SGD | 11.42 SGD | -0.89 | -9.57 | 1.1M | Off |
| 10 Jul 2026 | 16.70 SGD | 4.8% | 16.30 SGD | 11.36 SGD | -0.85 | -7.16 | 1.1M | Off |
| 3 Jul 2026 | 15.93 SGD | 0.6% | 16.25 SGD | 11.30 SGD | -0.89 | -7.56 | 162.1K | Off |
| 26 Jun 2026 | 15.84 SGD | -1.6% | 16.24 SGD | 11.25 SGD | -0.90 | -7.17 | 145.6K | Off |
| 19 Jun 2026 | 16.10 SGD | -0.4% | 16.22 SGD | 11.20 SGD | -0.84 | -5.59 | 376.4K | Off |
| 12 Jun 2026 | 16.17 SGD | 4.4% | 16.18 SGD | 11.15 SGD | -0.76 | -1.93 | 411.0K | Off |
| 5 Jun 2026 | 15.49 SGD | 0.5% | 16.13 SGD | 11.09 SGD | -0.65 | -6.35 | 252.0K | Off |
| 29 May 2026 | 15.42 SGD | -7.5% | 16.13 SGD | 11.04 SGD | -0.31 | -6.46 | 5.7M | On |
| 22 May 2026 | 16.67 SGD | -0.8% | 16.10 SGD | 10.99 SGD | -0.19 | 0.58 | 2.1M | On |
| 15 May 2026 | 16.81 SGD | -3.9% | 16.05 SGD | 10.94 SGD | -0.14 | 3.23 | 1.7M | On |
| 8 May 2026 | 17.49 SGD | 2.8% | 15.97 SGD | 10.88 SGD | -0.01 | 9.19 | 1.3M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.